T Th he e e ef ff fe ec ct t o of f t tr re ea at tm me en nt t o of f a ac cu ut te e l ly ym mp ph ho ob bl la as st ti ic c l le eu uk ke em mi ia a o on n m me ea an n e er ry yt th hr ro oy yt te e v vo ol lu um me e i in n c ch hi il ld dr re en n T Ti ir ra aj je e C Ce el lk ka an n, , N Ni ih ha al l Ö Öz zd de em mi ir r , , Z Ze ek ke er ri iy ya a
Material and Method:One hundred-twenty-five children with ALL were included in this retrospective study. The MCV values of the patients (age 1-15 years, 83 boys, 42 girls) at diagnosis, at induction/consolidation chemotherapy and after maintenance treatment were evaluated.
Results:The MCV values of the patients at diagnosis, at induction/consolidation chemotherapy and after maintenance treatment were 78,5+3,9 fl; 89,1+6,8 fl and 95,6+3,8 fl, respectively. On follow-up, MCV values were found to decrease with a mean of 1 fl per month after chemotherapy. The results of 15 relapsed patients were compared with results of 110 patients without relapse; there was no statistically significant difference in MCV values ( p>0.05).Conclusions: MCV was not found to be a significant parameter in relation to prognosis and relapse in children with ALL.